Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein

References

• Aylward M., Maddock J., Rees P. L. Natural oestrogen replacement therapy and blood clotting. Br Med J 1976; i: 220
   Google Scholar
• Bolton C. H. The effect of ethinyl oestradiol and conjugated equine oestrogens on plasma lipids in oophorectomised women. The Management of the Menopause and Post-Menopausal Years, S. Campbell. MTP Press, LancasterEngland 1976; 185–194
   Google Scholar
• Bonnar J. Effect of synthetic and natural oestrogens on the coagulation system in post-menopausal women. The Management of the Menopause and Post-Menopausal Years, S. Campbell. MTP Press, LancasterEngland 1976; 321–329
   Google Scholar
• Clark J. H., Paszko Z., Peck E. J., Jr. Nuclear binding and retention of the receptor estrogen complex: Relation to the agonistic and antagonistic properties of estriol. Endocrinology 1977; 100: 91
   PubMed Web of Science ®Google Scholar
• Damber M.-G., von Schoultz B., Stigbrand T., Carlström K. A radioimmunoassay for the pregnancy zone protein. Clin Chim Acta 1976; 66: 85
   PubMedGoogle Scholar
• Damber M.-G., Sandström B., von Schoultz B., Stigbrand T. A new and sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstet Gynecol Scand 1979; 58: 527
   PubMed Web of Science ®Google Scholar
• El Makhzangy M. N., Wynn V., Lawrence D. M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39
   PubMedGoogle Scholar
• Englund D. E., Johansson E. D. B. Endometrial effect of oral estriol treatment in postmenopausal women. Acta Obstet Gynecol Scand 1980; 59: 449
   PubMed Web of Science ®Google Scholar
• Gallagher J. C., Nordin B. E. C. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women, estrogens in the post-menopause. Front Hormone Res 1975; 3: 150–176, Karger, Basel
   PubMedGoogle Scholar
• Howard R. P., Keaty E. C. Evaluation of equilin 3-mono-sulfate and other estrogens. Arch Intern Med 1971; 128: 229
   Google Scholar
• Laurell C.-B., Rannevik G. A comparative study of plasma protein changes induced by danazol, pregnancy and estrogens. J Clin Endocrinol Metab 1979; 49: 719
   PubMed Web of Science ®Google Scholar
• Lauritzen C. The management of the pre-menopausal and the post-menopausal patient, ageing and estrogens. Front Horm Res 1973; 2: 2, Karger, Basel
   Google Scholar
• Lyrenäs S., Carlström K., Bäckström T., von Schoultz B. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17β. Br J Obstet Gynaecol 1981; 88: 181
   PubMedGoogle Scholar
• Moore D. E., Kawagoe S., Davajan V., Mishell D. R., Nakamura R. M. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroidbinding globulin by conjugated estrogens, mestranol and ethinyl estradiol. Am J Obstet Gynecol 1978; 130: 482
   PubMed Web of Science ®Google Scholar
• Musa B. U., Seal U. S., Doe R. P. Elevation of certain plasma proteins in man following estrogen administration: A dose-response relationship. J Clin Endocrinol Metab 1965; 25: 1163
   PubMed Web of Science ®Google Scholar
• Rudel H. W., Kincl F. A. The biology of antifertility steroids. Acta Endocrinol (Kbh) 1966; 51: 7, Suppl 105
   Google Scholar
• Ryan K. J., Engel L. L. The interconversion of estrone and estradiol by human tissue slices. Endocrinology 1953; 52: 287
   PubMed Web of Science ®Google Scholar
• Schwartz U., Hammerstein J. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity. Acta Endocrinol (Kbh) 1974; 76: 159
   Google Scholar
• Clinical Gynecologic Endocrinology and Infertility, 2nd ed, L. Speroff, R. H. Glass, N. G. Kase. The Williams and Wilkins Co., Baltimore 1978
   Google Scholar
• von Schoultz B. A quantitative study of the pregnancy zone protein in the sera of pregnant and puerperal women. Am J Obstet Gynecol 1974; 119: 792
   PubMed Web of Science ®Google Scholar
• von Schoultz B., Stigbrand T. Characterization of the pregnancy zone protein in relation to other α2-globulins of pregnancy. Biochim Biophys Acta 1974; 359: 303
   Google Scholar
• von Schoultz B., Damber M.-G., Stigbrand T. Biological and clinical significance of the immunosuppressive pregnancy zone protein (PZ). Protides of the Biological Fluids, 24th Colloquium, H. Peeters. Pergamon Press, Oxford 1976; 189–192
   Google Scholar
• Åstedt B. Low fibrinolytic activity of veins during treatment with ethinyl-oestradiol. Acta Obstet Gynecol Scand 1971; 50: 279
   PubMed Web of Science ®Google Scholar